Cargando…

Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2X(7)R signaling

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cognitive deficits. Two hallmarks of AD that cause chronic inflammation and lead to neuronal dysfunction and damage are tau tangles and amyloid plaques. Microglial cells, the primary immune cells of the central...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suresh, Pavithra, Phasuk, Sarayut, Liu, Ingrid Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821819/ https://www.ncbi.nlm.nih.gov/pubmed/33505871 http://dx.doi.org/10.4103/tcmj.tcmj_144_20

Ejemplares similares

Microglia, seen from the CX(3)CR1 angle
por: Wolf, Yochai, et al.
Publicado: (2013)

Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation
por: Rowinska, Zuzanna, et al.
Publicado: (2017)

CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD
por: Falk, Mads Krüger, et al.
Publicado: (2014)

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection
por: Chen, Peiqing, et al.
Publicado: (2016)

Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
por: von Vietinghoff, Sibylle, et al.
Publicado: (2021)

The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2014)

Absence of CX3CR1 impairs the internalization of Tau by microglia
por: Bolós, Marta, et al.
Publicado: (2017)

Microglia and Aging: The Role of the TREM2–DAP12 and CX3CL1-CX3CR1 Axes
por: Mecca, Carmen, et al.
Publicado: (2018)

Sirtuin 3 promotes microglia migration by upregulating CX3CR1
por: Cao, Runjing, et al.
Publicado: (2019)

Ccl2, Cx3cr1 and Ccl2/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degeneration
por: Luhmann, Ulrich F.O., et al.
Publicado: (2013)

Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation
por: Zhang, Yikui, et al.
Publicado: (2018)

Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
por: Lu, Minmin, et al.
Publicado: (2022)

Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1(I249/M280)-expressing retina
por: Church, Kaira A., et al.
Publicado: (2023)

An overlooked subset of Cx3cr1(wt/wt) microglia in the Cx3cr1(CreER-Eyfp/wt) mouse has a repopulation advantage over Cx3cr1(CreER-Eyfp/wt) microglia following microglial depletion
por: Zhou, Kai, et al.
Publicado: (2022)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
por: Limatola, Cristina, et al.
Publicado: (2014)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
por: Pawelec, Paulina, et al.
Publicado: (2020)

Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis
por: Zheng, Jiao, et al.
Publicado: (2013)

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
por: Chaudhri, Apoorvi, et al.
Publicado: (2023)

CX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting
por: Wang, Xueting, et al.
Publicado: (2023)

The role of microglia and their CX3CR1 signaling in adult neurogenesis in the olfactory bulb
por: Reshef, Ronen, et al.
Publicado: (2017)

Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity
por: Zhao, Xiao-Feng, et al.
Publicado: (2019)

Cx3cr1-deficient microglia exhibit a premature aging transcriptome
por: Gyoneva, Stefka, et al.
Publicado: (2019)

CX3CR1 in multiple sclerosis
por: Rivest, Serge
Publicado: (2015)

Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration
por: Raoul, William, et al.
Publicado: (2010)

Differential Modulation of Retinal Degeneration by Ccl2 and Cx3cr1 Chemokine Signalling
por: Luhmann, Ulrich F. O., et al.
Publicado: (2012)

Fractalkine receptor chemokine (CX3CR1) influences on cervical and lumbar disc herniation
por: Oh, In-Soo, et al.
Publicado: (2015)

Ischemia-induced Neuronal Cell Death Is Mediated by Chemokine Receptor CX3CR1
por: Wang, Jinkun, et al.
Publicado: (2018)

VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis
por: Low, Sarah, et al.
Publicado: (2020)

Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
por: Bian, Chao, et al.
Publicado: (2015)

Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient
por: Siddiqui, Imran, et al.
Publicado: (2016)

CX3CR1 and malignant progression of glioma
por: Lee, Sungho, et al.
Publicado: (2021)

Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
por: Zhang, Huili, et al.
Publicado: (2012)

CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
por: Zhuang, Quan, et al.
Publicado: (2017)

CX3CL1–CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis
por: Fernández-Prieto, Marta, et al.
Publicado: (2019)

The chemokine receptor CX(3)CR1 is directly involved in the arrest of breast cancer cells to the skeleton
por: Jamieson-Gladney, Whitney L, et al.
Publicado: (2011)

CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
por: Tang, Zhiwei, et al.
Publicado: (2014)

CX(3)CR1(+) CD115(+) CD135(+) common macrophage/DC precursors and the role of CX(3)CR1 in their response to inflammation
por: Auffray, Cedric, et al.
Publicado: (2009)

Aspirin Action in Endothelial Cells: Different Patterns of Response Between Chemokine CX3CL1/CX3CR1 and TNF-α/TNFR1 Signaling Pathways
por: Szukiewicz, Dariusz, et al.
Publicado: (2015)

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
por: Sato, Michihito, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4u76l93ip2i5pbc2uu0oe9jd8l